[Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti
A
A
Verdiani
P
P
Di Carlo
S
S
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D013806:Theophylline / Q000008:administration & dosage* / Q000097:blood; D013997:Time Factors
D003692:Delayed-Action Preparations; D013806:Theophylline
Impiego di una nuova teofillina anidra ritardo ad unica somministrazione giornaliera nel trattamento dell'ostruzione bronchiale reversibile. Confronto con un preparato ritardo a duplice somministrazione quotidiana.